Want to see DE:GME full AI Analyst Report?
Geratherm Medical (GME) Financial Statements
Geratherm Medical Financial Overview
Geratherm Medical's market cap is currently $11.71M. The company's EPS TTM is $-0.14; its P/E ratio is -15.40; and it has a dividend yield of 4.65%. Geratherm Medical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.86M | $ 20.43M | $ 20.96M | $ 25.85M | $ 24.64M |
| Gross Profit | $ 2.37M | $ 12.78M | $ 6.27M | $ 6.38M | $ 16.32M |
| Operating Income | $ -1.31M | $ 1.76M | $ 1.70M | $ 1.39M | $ 589.73K |
| EBITDA | $ -154.63K | $ 2.95M | $ 4.20M | $ 3.37M | $ 2.20M |
| Net Income | $ -818.99K | $ 705.17K | $ 1.11M | $ 1.02M | $ 122.23K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 9.26M | $ 9.64M | $ 7.74M | $ 10.89M | $ 6.47M |
| Total Assets | $ 26.00M | $ 28.54M | $ 35.72M | $ 38.38M | $ 34.56M |
| Total Debt | $ 2.48M | $ 3.28M | $ 7.23M | $ 9.29M | $ 9.32M |
| Net Debt | $ -5.13M | $ -4.40M | $ 1.99M | $ 557.29K | $ 7.06M |
| Total Liabilities | $ 6.55M | $ 7.71M | $ 13.11M | $ 16.15M | $ 15.93M |
| Stockholders' Equity | $ 19.66M | $ 21.02M | $ 22.33M | $ 22.34M | $ 18.52M |
| Cash Flow | |||||
| Free Cash Flow | $ 1.22M | $ 1.23M | $ -212.00K | $ -133.00K | $ -353.00K |
| Operating Cash Flow | $ 1.39M | $ 1.87M | $ 1.47M | $ 2.79M | $ 917.00K |
| Investing Cash Flow | $ -328.00K | $ 3.82M | $ -2.09M | $ -767.00K | $ 3.00K |
| Financing Cash Flow | $ -1.31M | $ -2.69M | $ -3.09M | $ 4.35M | $ -3.52M |
Currency in EUR